Form4insider filings, from the source

SEC Form 4 · accession 0001232524-15-000105

Jazz Pharmaceuticals plc · JAZZ

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Karen L. Smith
Officer — Global Head of R&D and CMO
Period of report
May 11, 2015
Accepted (ET)
May 13, 2015 · 6:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Ordinary SharesMay 11, 2015A6,830$0.00A6,830D
Ordinary SharesMay 11, 2015A275$0.00A7,105D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Incentive Stock Option (right to buy)F3$176.51May 11, 2015A2,264A—May 10, 2025Common Stock2,2642,264D
Non-Qualified Stock Option (right to buy)F3$176.51May 11, 2015A15,516A—May 10, 2025Ordinary Shares15,51615,516D

Explanation of responses